Vontobel Holding
RVMD icon

Vontobel Holding’s Revolution Medicines RVMD Stock Holding History

Vontobel Holding’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$711K Buy
3,799
+99
+3% +$14.5K ﹤0.01% 931
2026
Q1 		$360K Buy
+3,700
New +$374K ﹤0.01% 948
2024
Q4 		– Sell
-5,432
Closed -$246K – 1160
2024
Q3 		$246K Buy
+5,432
New +$237K ﹤0.01% 965

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vontobel Holding's RVMD Position: Q2 2026 in Review

Vontobel Holding increased its Revolution Medicines (RVMD) stake by 2.7% in Q2 2026, buying an estimated $14.5K and bringing the position to 3,799 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

Vontobel Holding first reported a position in RVMD in Q3 2024 and has held it in 3 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Vontobel Holding held 3,799 shares of Revolution Medicines worth $711K as of Q2 2026.
  • Vontobel Holding bought 99 Revolution Medicines shares in Q2 2026, an estimated $14.5K.
  • Revolution Medicines made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #931 holding.
  • Vontobel Holding first reported a position in Revolution Medicines in Q3 2024 and has held it in 3 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.